Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis

Company Overview

Aoxing Pharmaceutical (OTCMKTS: AOXG) is a China-based company engaged in the research, development, manufacture and sale of active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The company’s product portfolio includes a variety of small-molecule APIs and botanical extracts designed to meet the needs of pharmaceutical, nutraceutical and cosmetic customers. Aoxing Pharmaceutical also offers custom synthesis and contract manufacturing services to support specialized client requirements.

Headquartered in China, Aoxing Pharmaceutical operates manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards and other quality protocols. Its in-house R&D team focuses on process optimization, scale-up of new compounds and continuous improvement of production efficiencies. These capabilities enable the company to maintain tight quality control over its product lines and support ongoing pipeline development.

Traded under the ticker AOXG on the OTC Markets, Aoxing Pharmaceutical serves domestic Chinese customers alongside select international partners in Asia and other regions. Its end markets include pharmaceutical manufacturers, healthcare providers and research institutions. The company continues to explore growth through expansion of its API offerings, enhancements in manufacturing technology and collaborations aimed at broadening its geographic footprint.

Key Stats

• Today's Range: $0.0050 to $0.0050
• 50-Day Range: $0.0050 to $0.0107
• 52-Week Range: $0.0046 to $0.0178
• Volume: 12,000 shs
• Average Volume: 7,741 shs
• Market Capitalization: $1.91 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AOXG Stock Analysis - Frequently Asked Questions

How have AOXG shares performed this year?

Aoxing Pharmaceutical's stock was trading at $0.0071 at the beginning of the year. Since then, AOXG shares have decreased by 29.6% and is now trading at $0.0050.

How were Aoxing Pharmaceutical's earnings last quarter?

Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) issued its earnings results on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $6.56 million for the quarter.

How do I buy shares of Aoxing Pharmaceutical?

Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aoxing Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC) and EDAP TMS (EDAP).

Company Calendar

• Last Earnings: 5/16/2016
• Today: 9/18/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AOXG
• Previous Symbol: NYSEMKT:AXN
• CIK: N/A
• Web: axzyen.icm.cn
• Phone: (646) 367-1747
• Fax: 646-367-1747
• Employees: 350
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 381,210,000
• Free Float: 313,354,000
• Market Cap: $1.91 million
• Optionable: Not Optionable
• Beta: 7.38